tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

PSNL Stock Latest News

PSNL Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Pre-EarningsPSNL Earnings Report this Week: Is It a Buy, Ahead of Earnings?
5h ago
PSNL
Personalis Inc. Advances TNBC Treatment with Innovative ctDNA Study
PremiumCompany Announcements
Personalis Inc. Advances TNBC Treatment with Innovative ctDNA Study
6d ago
PSNL
Personalis announces NeXT Personal data from AstraZeneca’s Phase 3 LAURA trial
PremiumThe Fly
Personalis announces NeXT Personal data from AstraZeneca’s Phase 3 LAURA trial
17d ago
AZN
PSNL
Personalis management to meet with Piper Sandler
PremiumThe Fly
Personalis management to meet with Piper Sandler
1M ago
PSNL
Personalis collaborates with Yale Cancer Center over CATE clinical trial
PremiumThe Fly
Personalis collaborates with Yale Cancer Center over CATE clinical trial
2M ago
PSNL
Buy Rating for Personalis Driven by Promising Clinical Data and Strategic Reimbursement Efforts
PremiumRatingsBuy Rating for Personalis Driven by Promising Clinical Data and Strategic Reimbursement Efforts
2M ago
PSNL
Personalis reports data from AstraZeneca phase 3 clinical trial in lung cancer
Premium
The Fly
Personalis reports data from AstraZeneca phase 3 clinical trial in lung cancer
2M ago
AZN
PSNL
Personalis Secures New VA Contract Task Order
Premium
Company Announcements
Personalis Secures New VA Contract Task Order
2M ago
8K
PSNL
Cathie Wood’s ARK Investment buys 133.3K shares of Personalis today
PremiumThe Fly
Cathie Wood’s ARK Investment buys 133.3K shares of Personalis today
3M ago
PSNL
Cathie Wood ‘Buys the Dip’ in Block Stock; Sells Shopify Shares
PremiumMarket News
Cathie Wood ‘Buys the Dip’ in Block Stock; Sells Shopify Shares
3M ago
GH
XYZ
Personalis Earnings Call: Growth Amidst Financial Challenges
PremiumCompany Announcements
Personalis Earnings Call: Growth Amidst Financial Challenges
3M ago
PSNL
Personalis price target lowered to $6 from $8 at BTIG
PremiumThe Fly
Personalis price target lowered to $6 from $8 at BTIG
3M ago
PSNL
Personalis price target lowered to $8.50 from $9 at H.C. Wainwright
PremiumThe FlyPersonalis price target lowered to $8.50 from $9 at H.C. Wainwright
3M ago
PSNL
Personalis: Strong Molecular Testing Growth and Strategic MRD Focus Support Buy Rating
Premium
Ratings
Personalis: Strong Molecular Testing Growth and Strategic MRD Focus Support Buy Rating
3M ago
PSNL
Personalis Reports Q2 2025 Financial Results
Premium
Company Announcements
Personalis Reports Q2 2025 Financial Results
3M ago
PSNL
Personalis: Buy Rating Amidst Challenges and Opportunities in MRD Growth
PremiumRatings
Personalis: Buy Rating Amidst Challenges and Opportunities in MRD Growth
3M ago
PSNL
Personalis reports Q2 EPS (23c), consensus (24c)
PremiumThe Fly
Personalis reports Q2 EPS (23c), consensus (24c)
3M ago
PSNL
Personalis sees Q3 revenue $12M-$14M, consensus $18.9M
PremiumThe Fly
Personalis sees Q3 revenue $12M-$14M, consensus $18.9M
3M ago
PSNL
Personalis cuts FY25 revenue view to $70M-$80M from $80M-$90M
PremiumThe Fly
Personalis cuts FY25 revenue view to $70M-$80M from $80M-$90M
3M ago
PSNL
Personalis price target raised to $8 from $7 at BTIG
PremiumThe FlyPersonalis price target raised to $8 from $7 at BTIG
3M ago
PSNL
Closing Bell Movers: Ultragenyx slumps 25% on UX143 recommendation
Premium
The Fly
Closing Bell Movers: Ultragenyx slumps 25% on UX143 recommendation
4M ago
KLG
MEI
Personalis Expands Agreement with Tempus AI for Cancer Test
Premium
Company Announcements
Personalis Expands Agreement with Tempus AI for Cancer Test
4M ago
8K
PSNL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >